NCT04038619View on ClinicalTrials.gov

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
ColitisDiarrheaMalignant Genitourinary System NeoplasmMelanomaLung CancerOvarian CancerUterine CancerBreast CancerCervical Cancer
Interventions
PROCEDURE

Fecal Microbiota Transplantation

Undergo FMT via colonoscopy

DRUG

Loperamide

Given PO

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER